SINOPHARM GROUP 1/5/O.N. (X2S1) — Net Asset Momentum
SINOPHARM GROUP 1/5/O.N. (X2S1) recorded a net asset momentum of 5.9% as of December 2025, with net assets of €134.16 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check SINOPHARM GROUP 1/5/O.N. (X2S1) tangible equity ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
SINOPHARM GROUP 1/5/O.N. Net Asset Momentum (2021–2025)
This chart tracks SINOPHARM GROUP 1/5/O.N.'s year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +5.9%, with net assets of €134.16 Billion EUR as of December 2025. Read SINOPHARM GROUP 1/5/O.N. balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for SINOPHARM GROUP 1/5/O.N. (2021–2025)
The table below shows the complete annual net asset history for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market cap of SINOPHARM GROUP 1/5/O.N..
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €134.16 Billion | €390.36 Billion | €256.20 Billion | ▲ +5.9% |
| 2024 | €126.69 Billion | €392.83 Billion | €266.14 Billion | ▲ +5.3% |
| 2023 | €120.32 Billion | €383.39 Billion | €263.08 Billion | ▲ +9.3% |
| 2022 | €110.07 Billion | €364.78 Billion | €254.71 Billion | ▲ +10.5% |
| 2021 | €99.65 Billion | €335.41 Billion | €235.76 Billion | — |